Neurology News and Research

Latest Neurology News and Research

Zale Lipshy University Hospital receives 2013 Press Ganey Beacon of Excellence Award

Zale Lipshy University Hospital at UT Southwestern Medical Center received the 2013 Press Ganey Beacon of Excellence Award for patient satisfaction, one of only three academic medical centers in the nation and one of 26 health care facilities selected nationally to receive that distinction.

21 Nov 2013

Multiple sclerosis researchers receive NMSS drug development grant

A $500,000 drug development grant from the National Multiple Sclerosis Society was awarded to a partnership between a multiple sclerosis research team at the Icahn School of Medicine at Mount Sinai and Karyopharm Therapeutics Inc., a clinical stage pharmaceutical company. Dr. Patrizia Casaccia, MD, PhD, Professor in the Departments of Neuroscience and Genetics and Genomics, at Icahn School of Medicine at Mount Sinai, will be the academic lead.

21 Nov 2013

Chicago Stroke Trials Consortium to build infrastructure to support clinical trials for stroke prevention

A new network dedicated to advancing research and therapies for stroke is forming in Chicago thanks to $2 million in grants from the National Institutes of Health. The Chicago Stroke Trials Consortium is a partnership among Northwestern Medicine-, Ann & Robert H. Lurie Children's Hospital of Chicago, John H. Stroger Jr. Hospital of Cook County, Loyola University Medical Center, Rehabilitation Institute of Chicago, Rush University Medical Center, and University of Chicago Medicine that will build an infrastructure to support clinical trials for stroke prevention, treatment and recovery.

21 Nov 2013

Metal coil therapy may provide same benefits as major surgery for COPD

Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.

20 Nov 2013

Adding corticosteroid fluocortolone with standard therapy improves visual acuity in NAION patients

Nonarteritic anterior ischemic optic neuropathy is one of the leading causes of sudden and irreversible loss of vision in older adults. In a prospective randomized trial of 60 patients with NAION, investigators have shown that the addition of the corticosteroid fluocortolone to standard therapy significantly improves both short- and long-term visual acuity, especially when given soon after the onset of symptoms. Their results are published in Restorative Neurology and Neuroscience.

20 Nov 2013

Non-specialist health workers provide treatment for people with MNS problems in developing countries

Non-specialist health workers are beneficial in providing treatment for people with mental, neurological and substance-abuse (MNS) problems in developing countries - where there is often a lack of mental health professionals - according to a new Cochrane review.

20 Nov 2013

New biomarker predicts that concussion victims may have cognitive dysfunction following mTBI

A new blood biomarker correctly predicted which concussion victims went on to have white matter tract structural damage and persistent cognitive dysfunction following a mild traumatic brain injury.

20 Nov 2013

Stroke may be associated with smoking synthetic marijuana

Add stroke to the list of severe health hazards that may be associated with smoking synthetic marijuana, popularly known as spice or K2, a University of South Florida neurology team reports.

20 Nov 2013

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

The Boston Scientific Corporation Vercise Deep Brain Stimulation System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.

19 Nov 2013

BIDMC pilot study shows promise for age-related cognitive disorders

It's well known that the brains of meditators change, but it's not entirely clear what those changes mean or how the changes might benefit the meditator. A new pilot study led by researchers at Beth Israel Deaconess Medical Center suggests that the brain changes associated with meditation and stress reduction may play an important role in slowing the progression of age-related cognitive disorders like Alzheimer's disease and other dementias.

18 Nov 2013

£20M research centre opened to investigate exciting new therapies for neurodegenerative diseases

A specialist £20 million research centre, funded by the Wolfson Foundation and dedicated to carrying out first-in-human studies, opens in London today (15th November). Researchers at the Leonard Wolfson Experimental Neurology Centre (LWENC) will investigate exciting new therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's.

16 Nov 2013

High school sports played at higher altitudes linked with reduction in concussion rates

According to a recent study done by doctors at Cincinnati Children's Hospital Medical Center, high school athletes who play collision sports at higher altitudes are less likely to suffer from concussions than those who play at lower altitudes.

15 Nov 2013

European Commission grants marketing authorization for Bayer HealthCare's Xofigo injection

Bayer HealthCare announced today that the European Commission has granted marketing authorization for Xofigo (radium Ra 223 dichloride) solution for injection for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases. This decision follows a positive recommendation from the European Committee for Medicinal Products for Human Use in September of this year.

15 Nov 2013

Researchers create new statistical tools to find clues about cancer from raw data

Researchers at Rice University, Baylor College of Medicine (BCM) and the University of Texas at Austin are working together to create new statistical tools that can find clues about cancer that are hidden like needles in enormous haystacks of raw data.

15 Nov 2013

ACADIA Pharmaceuticals initiates pimavanserin Phase II trial in ADP patients

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has initiated a Phase II feasibility trial designed to examine the efficacy and safety of pimavanserin as a treatment for patients with Alzheimer's disease psychosis.

15 Nov 2013

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

After years of planning, construction and preparation, Kaiser Permanente will open the doors to a brand new specialty center in Lone Tree on December 2nd. This is the largest construction project and the most significant addition to the health plan's brick-and-mortar presence in Colorado in nearly a decade.

15 Nov 2013

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

NeuroPace, Inc. today announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.

14 Nov 2013

Parkinson’s biomarker could be only skin deep

Deposits of α-synuclein in cutaneous nerves could represent a noninvasive biomarker for Parkinson’s disease, say researchers.

14 Nov 2013

Depression link to Parkinson’s risk bolstered

A large retrospective study supports the notion that depression may be an independent risk factor for Parkinson’s disease.

14 Nov 2013

People with higher pulse pressure more likely to have Alzheimer's biomarkers in cerebral spinal fluid

People in middle age who have a high blood pressure measure called pulse pressure are more likely to have biomarkers of Alzheimer's disease in their spinal fluid than those with lower pulse pressure, according to research published in the November 13, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

14 Nov 2013

Neurology News and Research

Latest Neurology News and Research

Zale Lipshy University Hospital receives 2013 Press Ganey Beacon of Excellence Award

Multiple sclerosis researchers receive NMSS drug development grant

Chicago Stroke Trials Consortium to build infrastructure to support clinical trials for stroke prevention

Metal coil therapy may provide same benefits as major surgery for COPD

Adding corticosteroid fluocortolone with standard therapy improves visual acuity in NAION patients

Non-specialist health workers provide treatment for people with MNS problems in developing countries

New biomarker predicts that concussion victims may have cognitive dysfunction following mTBI

Stroke may be associated with smoking synthetic marijuana

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

BIDMC pilot study shows promise for age-related cognitive disorders

£20M research centre opened to investigate exciting new therapies for neurodegenerative diseases

High school sports played at higher altitudes linked with reduction in concussion rates

European Commission grants marketing authorization for Bayer HealthCare's Xofigo injection

Researchers create new statistical tools to find clues about cancer from raw data

ACADIA Pharmaceuticals initiates pimavanserin Phase II trial in ADP patients

Kaiser Permanente to open doors to brand new specialty center in Lone Tree, Colorado

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

Parkinson’s biomarker could be only skin deep

Depression link to Parkinson’s risk bolstered

People with higher pulse pressure more likely to have Alzheimer's biomarkers in cerebral spinal fluid

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Neurology News and Research

Latest Neurology News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in